Marked Chart Marked Chart Closed

The Marked Chart Wire · Business

Fresenius Guidance

Fresenius Medical Care maintains full-year sales target

The company reaffirmed its fiscal 2026 revenue guidance of $23.764 billion, which exceeds the analyst estimate of $22.490 billion.

FMS+0.6%

Illustration for the Business desk

The stocks in this story

  1. FMS+0.6%Fresenius Medical$22.61

Prices from Before the open · based on Mon close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Business news

Illustration for the Business desk

DigitalOcean

DigitalOcean beats Q3 results, raises guidance on AI demand

DigitalOcean reported third-quarter revenue of $321 million, beating estimates, and raised full-year guidance. AI customer annual recurring revenue jumped 288 percent to $376 million as the company targets more than 60 percent revenue growth in 2027.

DOCN+0.2%

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.